The federal agency has recommended that healthcare workers self-report symptoms and not work if ill.
EDITOR’S NOTE: On March 5, the Centers for Disease Control and Prevention (CDC) held a call to update the provider community on the latest guidance related to COVID-19. During the call, several CDC physicians described the ever-changing landscape of the screening, diagnosis, and care for patients with COVID-19 and suspected patients. RACmonitor.com asked Dr. Ronald Hirsch of R1RCM, a RACmonitor editorial board member, to listen in and provide some notes for our readers.
According to the participants on the CDC COVID-19 call Thursday, there are 100 cases diagnosed in the U.S., 30 of which involved patients who had recently traveled to an area where COVID-19 is known to be present, and 17 with contact with known cases. The number is fluid, and there are many investigations ongoing.
“The most encouraging news was that the capacity to test patients is rapidly increasing,” reported Dr. Ronald Hirsch, who noted that Quest Diagnostics, a national lab company, will have the capacity to perform the test as of March 9, with a very high volume. “Those tests will be performed at their West Coast facility, so there will be no point-of-care results available.”
Hirsch said that one of the biggest frustrations expressed by providers is the inability to test for COVID-19 if the patient did not meet the strict screening criteria set by public health labs due to the limited test kit availability. This addition, along with other labs getting test kits, will help greatly.
Hirsch said the conference leaders also discussed mortality rates as a constantly moving number, with new data being produced, especially from China. The overall pattern does suggest that younger, healthy people have a very low mortality rate, and older patients and those with chronic illnesses have a significantly higher rate.
“Of those patients in China who developed pneumonia, 20 percent went on to acute respiratory distress syndrome (ARDS),” Hirsch said, citing the discussion of the conference call presenters. “Children have a very low risk of not only mortality, but also severe illness, with only one report of an infant in China who developed acute respiratory failure.”
According to the conference call participants, the overall rates suggest that 80 percent of patients will have a mild illness, and 20 percent will have moderate or severe illness that could require hospital care. Worth noting, according to Hirsch, is that there appears to be a trend of worsening in the second week of illness, so vigilance in monitoring of homebound patients is warranted.
“Clinically, COVID-19 appears to present like a typical respiratory illness, with fever and cough most common,” Hirsch said. “Patients may also have myalgia, fatigue, and sore throat, and some patients have reported nausea and diarrhea prior to the onset of respiratory symptoms. Rarely there is hemoptysis.”
Physicians leading the discussion during the call reported that lab testing tends to show leukopenia in two-thirds of patients, and often, profound lymphopenia. One-third of patients have elevated liver function tests, and it appears that procalcitonin is of no value. Imaging is best done with chest X-ray, and although there are typical findings on CT scan, there have been reports of false-negative studies in patients with confirmed COVID-19, so they do not recommend it as a diagnostic test, instead continuing to recommend swab testing for RT-PCR.
Hirsch learned during the call that treatment remains supportive, with many trials in the U.S. and around the world of various anti-viral agents and compassionate use of a promising antiviral from Gilead. Hirsch said the speakers made it clear that there is no role for corticosteroids, unless there is another compelling indication for them, as steroids can increase viral replication.
“On the prevention front,” Hirsch said, “the speakers all emphasized what we have been hearing: avoidance of exposure is key. Patients must be screened carefully and immediately placed in contact and droplet precautions to prevent transmission to healthcare workers.”
Hirsch said one speaker also offered what he described as “alternative methods of patient contact, such as telehealth,” that should be used. The speakers also noted that they are regularly updating their guidance on monitoring of healthcare workers for signs and symptoms of COVID-19, both to protect patients and to ensure that healthcare workers get the proper care.
“Because of the growing number of cases, the recent change was to recommend healthcare workers self-report symptoms and not work if ill,” said Hirsch. “The potential shortage of N95 masks to protect healthcare workers is being addressed, with waivers being drafted at the Food and Drug Administration (FDA) to allow certain ‘industrial’ respirators, as used in construction and manufacturing, to be used in hospitals.”
Hirsch emphasized that his summary should not be considered official guidance and that healthcare workers should consult the CDC COVID-19 website for up-to-date and constantly updated information. He also said that healthcare workers would find a separate page for nearly any scenario, including the possible exposure of a healthcare worker, guidance for EMTs, guidance for coordinating home care of a patient with COVID-19, and much more.
On a related note, CMS on Thursday announced that it has developed a second Healthcare Common Procedure Coding System (HCPCS) code that can be used by laboratories to bill for certain COVID-19 diagnostic tests to help increase testing and track new cases. In addition, the agency released new fact sheets that explain Medicare, Medicaid, Children’s Health Insurance Program, and Individual and Small Group Market Private Insurance coverage for services.
“CMS continues to leverage every tool at our disposal in responding to COVID-19,” CMS Administrator Seema Verma said in a statement. “Our new code will help encourage doctors and laboratories to use these essential tests for patients who need them. At the same time, we are providing critical information to our 130 million beneficiaries, many of whom are understandably wondering what will be covered when it comes to this virus. CMS will continue to devote every available resource to this effort, as we cooperate with other government agencies to keep the American people safe.”
Last month, CMS developed the first HCPCS code (U0001) to bill for tests and track new cases of the virus; this code is used specifically for CDC testing laboratories to test patients for SARS-CoV-2. The second HCPCS billing code (U0002) announced Thursday allows laboratories to bill for non-CDC laboratory tests for SARS-CoV-2/2019-nCoV (COVID-19).
Toward the end of last month, the FDA issued a new, streamlined policy for certain laboratories to develop their own validated COVID-19 diagnostics. This second HCPCS code may be used for tests developed by these additional laboratories when submitting claims to Medicare or health insurers.
CMS reported that the Medicare claims processing systems will be able to accept these new codes starting on April 1, 2020, for dates of service on or after Feb. 4, 2020. Local Medicare Administrative Contractors (MACs) are responsible for developing the payment amount for claims they receive for these newly created HCPCS codes in their respective jurisdictions until Medicare establishes national payment rates, CMS said, further noting that laboratories may seek guidance from their MAC on payment for these tests prior to billing for them.
EDITOR’S NOTE: This article was originally published Monday, Dec. 8 by RACmonitor as a special bulletin. Many people are still seething mad about Aetna’s devious
Once again, a well-known consulting organization has mischaracterized the “incident-to” requirements. A few months ago, I wrote about an article that asserted you can’t bill
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
